Chronic Atrophic Gastritis
Conditions
Interventions
Control group:Western medicine
Experimental group:Electroacupuncture combined with western medicine
Sponsors
Nanjing Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. CAG patients who meet the above western diagnostic criteria; 2. Patients with liver and stomach qi stagnation syndrome according to the above TCM diagnostic criteria; 3. Hp negative confirmed by gastroscopy and pathological examination or Hp negative after eradication treatment; 4. Aged between 18 and 75, with no gender limitation; 5. Patients who did not receive acupuncture treatment or any medicine (Traditional Chinese medicine, Western medicine, patent Chinese medicine, etc.) for 14 consecutive days before inclusion; 6. Informed consent of patients should be obtained through communication, and patients should voluntarily and actively cooperate with diagnosis and treatment and other related research processes.
Exclusion criteria
Exclusion criteria: 1. Unclear syndrome differentiation or too many other syndromes, inconsistent with the TCM diagnostic criteria involved in this study; 2. Patients with intraepithelial neoplasia or gastric cancer indicated by gastroscopy or pathological biopsy, metastasis of cancer cells or other systemic malignancies detected by imaging examination; 3. Those who have had previous stomach surgery; 4. Used traditional Chinese and Western medicine to treat the disease and influence the observation of curative effect within 3 months of the onset of this disease; 5. Patients with primary diseases such as serious damage to heart, brain, liver, kidney and hematopoietic system. People with cognitive, language or mental disabilities; 6. Women who are pregnant or planning to become pregnant and women who are breastfeeding; 7. Allergic constitution and those who are allergic to drugs needed in this study; 8. Within six months or are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standard table of gastric mucosa grading and scoring under gastroscopy;Histopathological grading standard table;TCM syndrome integral record form; | — |
Secondary
| Measure | Time frame |
|---|---|
| GEDPRO - CG scale;Follow-up investigation of recurrence rate; | — |
Countries
China
Contacts
Public ContactZhang Cairong
Outcome results
None listed